If you would like further information, please do not hesitate to contact the chief investigators team.
3TR Clinical Trials Team
Email: emrclinicaltrials@qmul.ac.uk
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking(JU) under grant agreement No 831434.
The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.
The content of this website reflects only the author's view and JU is not responsible for any use that may be made of the information it contains.